retatrutide nejm Late breaking at #ADA23: In this trial involving participants with obesity, 48 weeks of treatment with retatrutide, an agonist of the GIP, GLP-1, and GCG receptors, resulted in substantial reductions in body Retatrutide vs Wegovy: which works

While many are familiar with Platelet-Rich Plasma (PRP) , GFT is often considered the modern gold standard

Polycystic Ovary Syndrome: Definition, Aetiology, Diagnosis and Treatment

The Pharmaceutical Benefits Advisory Committee will need to weigh the broad availability of incretin analogues for obesity management against the long-term health and economic costs of obesity to the Australian community

While the FDA states some GLP-1 medications may be used for type 2 diabeteswhen a healthcare provider determines the benefits outweigh potential harmsthese medications should not be used for weight loss during pregnancy

At 25C (77F), the medication showed measurable changes over extended periods, while exposure to 40C (104F) and higher temperatures accelerated degradation substantially